002281:SZSEAccelink Technologies Co,Ltd. Analysis
Data as of 2026-09-07 - not real-time
CN¥184.47
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At ¥184.47, Accelink Technologies Co,Ltd. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 4.3%. With RSI at 52.3 the momentum picture is neutral, alongside a bullish MACD signal. Watch ¥160.31 as support and ¥202.38 as the nearer resistance level.
Valuation screens as overvalued: a P/E of 128.1 sits above the sector average of 33.2. Analyst price targets sit 10.6% above the current price. Revenue is growing at 27.0% on a 8.7% profit margin. The 0.11% dividend yield looks stretched against payout coverage.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 88.5%, a beta of 0.84 and a maximum drawdown of 44.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Valuation screens as overvalued: a P/E of 128.1 sits above the sector average of 33.2. Analyst price targets sit 10.6% above the current price. Revenue is growing at 27.0% on a 8.7% profit margin. The 0.11% dividend yield looks stretched against payout coverage.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 88.5%, a beta of 0.84 and a maximum drawdown of 44.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Barron's12dAccelink Technologies Co. Ltd. AAccelink Technologies Co., Ltd. engages in the research, development,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 133.61
- MACD momentum is positive
- 30-day volatility of 88.5%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 128.1 versus sector average of 33.2
- Dividend yield of 0.11% looks stretched against payout coverage
- Trading above the 200-day average of 133.61
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 128.1 versus sector average of 33.2
- Dividend yield of 0.11% looks stretched against payout coverage
- Analyst targets imply +10.6% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth27.00%
Profit Margin8.70%
P/E Ratio128.1
ROE9.65%
ROA4.04%
Debt/Equity2.02
P/B Ratio10.6
Op. Cash FlowCN¥499.1M
Free Cash FlowCN¥-1285745792
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI52.3
SupportCN¥160.31
ResistanceCN¥202.38
MA 20CN¥179.19
MA 50CN¥190.51
MA 200CN¥133.61
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59
Valuation
Fair ValueCN¥21.37
Target PriceCN¥204.10
Upside/Downside10.64%
GradeOvervalued
TypeGrowth
Dividend Yield0.11%
Risk Assessment
Beta0.84
Volatility88.53%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.